Proposed neutrophil extracellular trap (NET) targeting strategies. Peptidyl arginine deiminase 4 (PAD4) inhibitors block PAD4-mediated citrullination of histones, thereby preventing heterochromatin decondensation and subsequent NET release. Recombinant thrombomodulin (rTM) can inhibit high mobility group box 1 protein (HMGB1), reducing capture and migration of tumor cells by NETs. DNAse I and chloroquine (CQ) degrade and decrease secretion of decondensed DNA, respectively, thereby reducing interactions of decondensed DNA with the receptor for advanced glycation end products (RAGE), preventing pancreatic stellate cell (PSC) activation and subsequent extracellular matrix (ECM) deposition. ROS, reactive oxygen species; MMPs, matrix metalloproteinases.